A 27-year-old Asian Indian female presented with chief complaints of repeated episodes of redness in both eyes (OU) for the past 1 year. The symptoms were insidious in onset with associated blurring of vision, floaters, and photophobia in OU. There was no history of any medical illnesses. Examination elsewhere revealed a 3.5 × 3 cm lobulated nodule in the superolateral quadrant of the left breast. She was diagnosed to have masquerade syndrome and referred to a higher center. On examination, the visual acuity recorded using Snellen's vision chart for distance vision was 20/40 OU. The intraocular pressure was 18 and 19 mmHg in the right eye (OD) and left eye (OS), respectively. Slit-lamp biomicroscopy revealed 1+ flare, 1+ cells, and fine dusting on the endothelial surface. No posterior synechiae were evident. Posterior segment showed media clarity grade 1, normal disc and vessels with anterior vitreous cells, and large, discrete, snow balls inferiorly OU [ Fig. 1 ].
Fluorescein angiography showed bilateral focal vascular (perivenular) sheathing with leakage along superior and inferior temporal vascular arcades [ Fig. 2 ]. She was advised Mantoux test, QuantiFERON TB Gold  , contrast-enhanced computerized tomography (CECT) of the chest, and Venereal disease research laboratory (VDRL). QuantiFERON and Mantoux test were positive (20 × 25 mm; necrotic) [ Fig. 1 ], and CECT chest showed 7 × 7 mm-sized pretracheal and precarinal lymph nodes, 12 × 1 1 mm-sized subcarinal lymph nodes on the right side of esophagus, and a few axillary lymph nodes measuring upto 22 × 15 mm. There was no evidence of pleural effusion. The blood samples were negative for VDRL.
Examination by the pulmonologist revealed palpable enlarged lymph nodes in the left axilla, which were fixed, discrete with hard consistency. Ultrasound (USG) of the breasts showed bilateral oval hypoechoic, well-circumscribed nodules. Histopathological analysis of the USG-guided biopsy of the left breast nodule showed benign duct adenosis. Biopsy sections from axillary lymph nodes revealed ill-formed epithelioid cells, granulomas, and Langhans giant cells. Ziehl-Neelsen staining for acid-fast bacilli was positive confirming the diagnosis of tuberculosis [ Fig. 3 ]. The patient was started on antitubercular therapy (ATT) along with oral steroids. Within 2 months of initiation of therapy, visual acuity improved to 20/20 OU with quiescent anterior chamber and resolved vitritis. The patient was advised to continue ATT (to complete the 9-month course) along with tapering of oral steroids.
Intermediate uveitis can be associated with a number of entities such as tuberculosis, sarcoidosis, Lyme's disease, and other rarer conditions such as demyelinating diseases and tubulointerstitial nephritis. [1, 2] It is well known that certain malignancies can masquerade as intraocular inflammation resulting in diagnostic delays. Systemic malignancies are known to present with vitreous inflammation (intermediate uveitis-like clinical presentation along with vasculitis). Our patient was initially misdiagnosed elsewhere as breast malignancy related uveitis. [3] However, a detailed systemic examination, including basic investigations for infectious etiologies, and invasive biopsies (including axillary lymph node and breast nodule) provided the accurate diagnosis in our patient. Tuberculosis is an important cause of intermediate uveitis in endemic areas. [4, 5] Therefore, in such cases, the ophthalmologists' must work closely with physicians of other specialties including radiologists, pulmonologists/infectious disease specialists, general surgeons, and pathologists to provide appropriate therapy to the patient. This photoessay highlights the importance of tissue diagnosis and meticulous systemic assessments which aid in establishing a timely diagnosis for an otherwise well-known entity.
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